Trial
NCT03254186
Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Emory University
Collaborators
Atlanta Clinical and Translational Science Institute
Condition
Tardive Dyskinesia
Intervention
Propranolol Hydrochloride
Why stopped
No participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-26